Hybridon Names New CEO | GenomeWeb

NEW YORK, July 30 – Hybridon named Stephen Seiler CEO, effective September 1, the company announced Monday.

Seiler replaces acting CEO and chief scientific officer Sudhir Agrawal, who stepped into the interim role when Hybridon’s CEO E. Andrews Grinstead took medical leave and subsequently died in February. Grinstead had been president and CEO since 1991.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.